The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H, Luo YB, Wu W, Zhang L, Wang Z, Dai Z, Feng S, Cao H, Cheng Q, Liu Z.
Comput Struct Biotechnol J. 2021 Aug 14;19:4603-4618. doi: 10.1016/j.csbj.2021.08.019. eCollection 2021.
Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N, Zhu L, Wang L, Shen Z, Huang X.
Comput Struct Biotechnol J. 2022 Jun 18;20:3106-3119. doi: 10.1016/j.csbj.2022.06.039. eCollection 2022.
Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment.
Wang W, Zhang J, Wang Y, Xu Y, Zhang S.
Comput Struct Biotechnol J. 2022 Jun 24;20:3322-3335. doi: 10.1016/j.csbj.2022.06.046. eCollection 2022.
Cardiophrenic Lymph Node Metastasis of Ovarian High-grade Serous Carcinoma Showing Wild-type p53 Immunostaining Pattern and Aberrant CD56 Expression.
Kwon HJ, Oh M, Han J, Song SY, Kim HS.
Int J Surg Pathol. 2021 Dec;29(8):864-869. doi: 10.1177/10668969211006194. Epub 2021 Mar 25.
Supradiaphragmatic manifestations of papillary serous adenocarcinoma of the ovary.
Patel SV, Spencer JA, Wilkinson N, Perren TJ.
Clin Radiol. 1999 Nov;54(11):748-54. doi: 10.1016/s0009-9260(99)91178-9.
APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S, Li Y, Xu J, Shen L.
Neurol Res. 2024 Mar;46(3):227-242. doi: 10.1080/01616412.2023.2287340. Epub 2024 Jan 22.
Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
Gyftaki R, Liacos C, Politi E, Liontos M, Saltiki K, Papageorgiou T, Thomakos N, Haidopoulos D, Rodolakis A, Alevizaki M, Bamias A, Dimopoulos A.
Int J Gynecol Cancer. 2014 Jun;24(5):851-6. doi: 10.1097/IGC.0000000000000139.
Comprehensive analysis of the novel omicron receptor AXL in cancers.
Zhang WN, Li XP, Wang PF, Zhu L, Xiao XH, Dai YJ.
Comput Struct Biotechnol J. 2022;20:3304-3312. doi: 10.1016/j.csbj.2022.06.051. Epub 2022 Jun 27.
Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker.
Dong Q, Yan L, Xu Q, Hu X, Yang Y, Zhu R, Xu Q, Yang Y, Wang B.
Front Genet. 2022 Sep 1;13:944970. doi: 10.3389/fgene.2022.944970. eCollection 2022.
Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint.
Bai KH, Zhang YY, Li XP, Tian XP, Pan MM, Wang DW, Dai YJ.
Comput Struct Biotechnol J. 2022 Sep 17;20:5226-5234. doi: 10.1016/j.csbj.2022.09.021. eCollection 2022.
